MemoryXLTM, Vitamin-Nutraceutical Supplement, Improves Memory And Cognitive Performance In Both Alzheimer's Disease And In Adults Without Dementia

Main Category: Alzheimer's / Dementia
Also Included In: Neurology / Neuroscience
Article Date: 18 Sep 2009 - 3:00 PDT

email to a friend   printer friendly   opinions  

Thomas Shea, Ph.D, and his team of scientists, tested the effects of MemoryXL™ previously shown to improve cognitive performance in Alzheimer's disease (1)(2) on adults without dementia.

Dr. Shea said, "Adults without dementia improved within two weeks, and maintained that improvement over the course of a year." (3) The results will appear in a forthcoming issue of The Journal of Nutrition, Health and Aging.

Full details, including this and previously published clinical studies, are available at http://www.memxl.com.

Clinically Proven MemoryXL™ Now Available-over-the-Counter

MemoryXL™ requires no prescription, so treatment can start at the first sign of memory dysfunction, or even before any loss. There is no need to wait until a decline in memory is serious enough to warrant a diagnosis of Alzheimer's disease.

Pharmacies, vitamin stores and other retail outlets can now sell MemoryXL™ or it can be ordered online; it costs $59 per bottle of 60 pills, a one-month supply, with a special offer of two months supply for $99.00.

About MemoryXL, Inc.

MemoryXL™ was previously shown to increase cognitive performance and reduce agitation/irritation, for longer than two and a half years in mild to moderate Alzheimer's disease (1) and maintained cognitive performance and behavioral symptoms for six months when treatment was initiated in late-stage Alzheimer's disease (2). Laboratory studies demonstrate that MemoryXL™ reduced production of beta amyloid (which forms senile plaques) and phospho-tau (which forms neurofibrillary tangles) (4)(5), reduced levels of homocysteine (which causes oxidative damage to brain cells) (6)(7); maintained levels of the neurotransmitter acetylcholine (8) and may therefore be an important addition to cholinesterase inhibitor therapy.

Citations

1. Chan et al. Am J Alz Dis OtherDementias 2008 23:571
2. Remington et al. Am J Alz DisOther Dementias 2009 24:27
3. Chan et al. J Nutri Health Aging 2009 : in press
4. Chan& Shea. J Neurochem 2007; 102:753.
5. Chan& Shea. J Alz dis 2006; 9:399
6. Dhitavat et al. Brain Res 2005; 9:114
7. Tchantchou et al. J Alz dis 2008 14:323
8. Chan et al.J Health Nutr Aging 2008; 12:252.

Source
MemoryXL, Inc

• Additional
• References
• Citations